Pancreatic cancer: Current status and Challenges.

Muñoz, Amanda R; Chakravarthy, Divya; Gong, Jingjing; Halff, Glenn A; Ghosh, Rita; Kumar, Addanki P

Muñoz, Amanda R; Chakravarthy, Divya; Gong, Jingjing; Halff, Glenn A; Ghosh, Rita; Kumar, Addanki P.

Afiliación

Muñoz AR; Department of Urology, The University of Texas Health Science Center, San Antonio, TX.
Chakravarthy D; Department of Urology, The University of Texas Health Science Center, San Antonio, TX.
Gong J; Department of Surgery, The University of Texas Health Science Center, San Antonio, TX.
Halff GA; Department of Molecular Medicine, The University of Texas Health Science Center, San Antonio, TX.
Ghosh R; Department of Pharmacology, The University of Texas Health Science Center, San Antonio, TX.
Kumar AP; UT Health San Antonio Cancer Center, The University of Texas Health Science Center, San Antonio, TX.

Curr Pharmacol Rep ; 3(6): 396-408, 2017 Dec.

Article en En | MEDLINE | ID: mdl-29404265

Palabras clave

Chemotherapy; Gemcitabine; Natural products; Pancreatic cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Curr Pharmacol Rep Año: 2017 Tipo del documento: Article